Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men

Authors
Publication date
1 October 2017
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1097%2Fftd.0000000...
      Last time updated on 22/04/2021

      King's Research Portal

      redirect
      oaioai:kclpure.kcl.ac.uk:publicat...
      Last time updated on 28/09/2023